期刊文献+

表达HPV18晚期蛋白L1重组毕赤酵母在30L Sartorious生物反应器(C_(30)-3)中的培养与诱导工艺摸索及优化 被引量:1

Cultivation and Induction Process Exploration and Optimization of HPV 18 L1 Protein Expressing Pichia Pastorius in 30 L Sartotious Bioreactor
原文传递
导出
摘要 采用改良后的低盐培养基在30 L Sartorious生物反应器(C30-3)对表达18型人乳头瘤病毒(Human papillom avirus,HPV)晚期蛋白L1重组毕赤酵母进行培养,探讨了在重组毕赤酵母细胞积累阶段和HPV18晚期蛋白L1诱导表达阶段不同的培养基配方、p H值、温度、搅拌转速、溶氧(DO)、重组毕赤酵母细胞积累阶段甘油的补加方式、去除阻碍物甘油的去阻碍时间、重组毕赤酵母表达HPV18晚期蛋白L1阶段诱导剂甲醇的补加方式等工艺参数对表达HPV18晚期蛋白L1重组毕赤酵母的影响。优化后的低盐培养基更适合重组毕赤酵母细胞的生长;重组毕赤酵母细胞积累阶段的培养过程中维持培养液p H值5.0,温度31℃,DO 20%~25%,搅拌转速500 r/min,培养到第20 h开始以恒速补加3 000 m L 40%甘油溶液,培养至重组毕赤酵母细胞湿重≥190 g/L,停止甘油补加,继续培养重组毕赤酵母4 h,消耗阻碍HPV18晚期蛋白L1表达的甘油;之后进入重组毕赤酵母表达HPV18晚期蛋白L1诱导阶段,维持培养液p H值5.2,温度29℃,DO含量45%,搅拌转速600 r/min,控制培养液中甲醇浓度为4%在线补加甲醇,诱导60 h,HPV18晚期蛋白L1的表达量达到了311.43 mg/L。利用30 L Sartorious生物反应器(C30-3)对表达HPV18L1重组毕赤酵母进行培养,经过多次试验建立起了稳定的重组毕赤酵母表达HPV18晚期蛋白L1工艺。 Using improved low-salt medium,the recombinant HPV18L1 late protein was expressed by Pichia pastorius at 30 L Sartorious bioreactor( C30-3). Various parameters affecting expression of HPV18L1 protein in accumulation and induction phases,such as medium components,p H value,temperature,stirring speed,dissolved oxygen,addition of glycerol and methanol,were evaluated.The results showed that the optimized low-salt medium is more suitable for the growth of the yeast Pichia cells. During accumulation stage,p H of the culture medium 5. 0,temperature 31℃,DO content of 20% to 25% and stirring speed 500 r / min were maintained,3 000 m L of 40% glycerol solution was added at a constant feed rate for the first 20 h until the Pichia wet weight ≥190 mg / m L and then feeding of glycerol was stopped and Pichia was cultivated for additional 4 h to exhaust glycerol. After entering the recombinant Pichia expression HPV18L1 protein induced late stage,to maintain the culture p H5. 2,temperature 29 ℃,DO content of 45%,stirring speed 600 r / min,methanol concentration control culture medium supplemented with 4% methanol online and induction 60 h.Late HPV18L1 protein expression reached 311. 43 mg / L. 30 L Stable expression of recombinant HPV18L1 protein by Pichia at 30 L Sartorious bioreactor( C30-3) was established.
出处 《药物生物技术》 CAS 2015年第1期38-44,共7页 Pharmaceutical Biotechnology
基金 国家高技术研究发展计划(No.2012AA02A404)资助
关键词 HPV18晚期蛋白L1 重组毕赤酵母 生物反应器 甘油补加方式 饥饿期 甲醇补加方式 Late HPV18L1 protein,Recombinant Pichia pastoris,Bioreactor,Glycerol feeding,Starvation,Methanol feeding
  • 相关文献

参考文献7

  • 1Chris A. Staley,Amy Huang,Maria Nattestad,Kristin T. Oshiro,Laura E. Ray,Tejas Mulye,Zhiguo Harry Li,Thu Le,Justin J. Stephens,Seth R. Gomez,Allison D. Moy,Jackson C. Nguyen,Andreas H. Franz,Joan Lin-Cereghino,Geoff P. Lin-Cereghino.Analysis of the 5′ untranslated region (5′UTR) of the alcohol oxidase 1 ( AOX1 ) gene in recombinant protein expression in Pichia pastoris[J]. Gene . 2012 (2)
  • 2Ai-Lian Zhang,Tian-Yuan Zhang,Jin-Xian Luo,Ce-Yi Fu,Zhi Qu,Guo-Hui Yi,Dong-Xiao Su,Fa-Zhi Tu,Ying-Wen Pan.Inducible expression of human angiostatin by AOXI promoter in P. pastoris using high-density cell culture[J]. Molecular Biology Reports . 2009 (8)
  • 3Dan Wu,Yu-You Hao,Ju Chu,Ying-Ping Zhuang,Si-Liang Zhang.Inhibition of degradation and aggregation of recombinant human consensus interferon-α mutant expressed in Pichia pastoris with complex medium in bioreactor[J]. Applied Microbiology and Biotechnology . 2008 (6)
  • 4Jan Pfeffer,Sven Richter,Jens Nieveler,Carl-Erik Hansen,Rachid Bel Rhlid,Rolf D. Schmid,Monika Rusnak.High yield expression of Lipase A from Candida antarctica in the methylotrophic yeast Pichia pastoris and its purification and characterisation[J]. Applied Microbiology and Biotechnology . 2006 (5)
  • 5Theppanya Charoenrat,Mariena Ketudat-Cairns,Helle Stendahl-Andersen,Mehmedalija Jahic,Sven-Olof Enfors.Oxygen-limited fed-batch process: an alternative control for Pichia pastoris recombinant protein processes[J]. Bioprocess and Biosystems Engineering . 2005 (6)
  • 6Deschuyteneer Michel,Elouahabi Abdelatif,Plainchamp Dominique,Plisnier Michel,Soete Dominique,Corazza Yvon,Lockman Laurence,Giannini Sandra,Deschamps Marguerite.Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix?, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine. Human vaccines . 2010
  • 7Buonaguro Franco Maria,Tornesello Maria Lina,Buonaguro Luigi.Virus-like particle vaccines and adjuvants: the HPV paradigm. Expert review of vaccines . 2009

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部